Sign Up | Log In | What is SocialPicks?

2 pts

Opinion on CEPHEID (CPHD) Sector: Technology > Industry: Scientific & Technical Instr.
Bullish on CPHD ...

Dec 15, 2007 08:42 AM GMT

Vivek I

Return	Risk
-7.52%	MID

Analyst

Profile & Performance

Subscribe to author

Cepheid is best known for its GeneXpert molecular testing system. I give CPHD a short term buy rating due to the recent occurrences of MRSA. GeneXpert is used to test for MRSA in hospitals and Cepheid owns exclusive rights to that test which has been experiencing increasing demand.

CPHD: This call was made on 12/15/07 @ $24.43

Rating:	$24.43 (12/15/07)
Gain/Loss:	-45.68% in 707 days

+ Referring to this analysis:

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

Who voted on this idea?

Pavel Golyshev

N/A

12/29/2007

Ratings referring to this analysis

Agree

Disagree

Bullish on CPHD ...
Pavel Golyshev 12/29/2007

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.25%	378
2	Gerald Greene	18.14	+70.10%	208
3	stockmarketfunding.com	17.66	+25.70%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+75.30%	38

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
WM	Washington Mutual Inc
T	AT&T Inc
FRE	Freddie Mac
GS	Goldman Sachs Group Inc The
FSLR	First Solar Inc.
AMD	Advanced Micro Devices Inc

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

NVO		Diabetes Care: Global Investing Opportunities by Mike Havrilla
DNDN		BioMed News Bytes: CombinatoRx, Dendreon, Photocure, Pozen by Mike Havrilla
ONCY		Oncolytics Biotech Inc. down to 2,00 $ by Yannis Maarten
JNJ		Epinex Diagnostics: A New Paradigm for Diabetic Testing by Mike Havrilla
CERS		BioMed News Bytes: GeoVax, Cerus, Discovery Labs by Mike Havrilla

... more »

CEPHEID (CPHD)

SocialPicks Sentiment:

This Quarter's Sentiment:

All:

100.0%

Top:

100.0%

Get Daily Email Alerts

Subscribe to Vivek I

Receive Free Ideas Daily for This Sector

Latest Picks by Vivek I

Symbol	SP Sentiment	Return	Since
C		+85.38%	12/29/07
BZH		+40.51%	12/26/07
SINA		-0.88%	12/26/07
CTRP		+18.08%	12/26/07
VSL	N/A	n/a	12/25/07

View All >

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Opinion on CEPHEID (CPHD) Sector: Technology > Industry: Scientific & Technical Instr. Bullish on CPHD ...

Opinion on CEPHEID (CPHD) Sector: Technology > Industry: Scientific & Technical Instr.
Bullish on CPHD ...